ACAD   $14.76  -3.53% Market Closed After Close 14.67 -0.61%

ACADIA Pharmaceuticals Inc
Total Cash 500.94M
totalCashPerShare 3.02
EBITDA 34.27M
Total Debt 57.66M
quickRatio 1.809
currentRatio 2.158
Total Revenue 890.53M
debtToEquity 11.159
Revenue/Share 5.402
ROA 0.01832
ROE 0.066989996
grossProfits
freeCashflow 130.44M
operatingCashflow 80.53M
earningsGrowth 28.35
revenueGrowth 0.464
grossMargins 0.51343
ebitdaMargins 0.03849
operatingMargins 0.12579
profitMargins 0.03432
enterpriseValue 2.09B
forwardPE 18.222223
floatShares 108.45M
sharesOutstanding 165.88M
sharesShort 7.98M
sharesShortPriorMonth 10.27M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.00%
Short Ratio help_outline 5.86%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 3.115
Price To Book help_outline 4.74
earningsQuarterlyGrowth 28.97
netIncomeToCommon 30.57M
trailingEps 0.19%
forwardEps 0.81%
enterpriseToEbitda 61.11
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.14 3Q 2024
institutionsCount 370
lastUpdated Oct. 22, 2024, 3:19 a.m.